Abstract
Umbilical cord blood (UCB) is widely considered as a potential alternative to bone marrow for haematopoietic stem cells. Efforts on UCB research have now taken a step further with the establishment of numerous cord blood banks throughout the world. Our aim is to improve the efficiency and end product of our bank because of the high running costs and administrative workload involved as well as finding a correlation between the reasons for rejecting UCB units (such as a low volume collected/ cell count) and obstetric factors. In 16 months we obtained 683 cord blood units by withdrawing residual blood from the placenta. The units were cryopreserved within 24 hours of extraction in a volume of at least 60mL with a nucleated cells total of 800 per 106. Analysis of the blood was also performed to exclude any bacterial contamination. However, 340 (49.75%) of the collected units were discarded. The main reasons were: low volume; low cell counts; patient/ family history; bacterial contamination; freezing problems; unit misidentification and no informed consent. Our study indicates that monitoring the reasons for rejecting UCB units on a regular basis could save the precious resources wasted on such units by identifying suitable units beforehand.
Keywords: Haematopoietic stem cells, Umbilical cord, Cryopreservation, Cord blood bank, Nucleated cell counts
Letters in Drug Design & Discovery
Title: Good Practice in Umbilical Cord Blood Collection in Order to Identify Suitable Units Before Cryopreservation
Volume: 7 Issue: 3
Author(s): C. Pafumi, G. Gangarossa, A. Lupo, C. Randazzo, G. Abate, I. La Rosa, M. A. Palumbo, A. Iemmola, F. Gulino, M. Attard and A. C. Plesca
Affiliation:
Keywords: Haematopoietic stem cells, Umbilical cord, Cryopreservation, Cord blood bank, Nucleated cell counts
Abstract: Umbilical cord blood (UCB) is widely considered as a potential alternative to bone marrow for haematopoietic stem cells. Efforts on UCB research have now taken a step further with the establishment of numerous cord blood banks throughout the world. Our aim is to improve the efficiency and end product of our bank because of the high running costs and administrative workload involved as well as finding a correlation between the reasons for rejecting UCB units (such as a low volume collected/ cell count) and obstetric factors. In 16 months we obtained 683 cord blood units by withdrawing residual blood from the placenta. The units were cryopreserved within 24 hours of extraction in a volume of at least 60mL with a nucleated cells total of 800 per 106. Analysis of the blood was also performed to exclude any bacterial contamination. However, 340 (49.75%) of the collected units were discarded. The main reasons were: low volume; low cell counts; patient/ family history; bacterial contamination; freezing problems; unit misidentification and no informed consent. Our study indicates that monitoring the reasons for rejecting UCB units on a regular basis could save the precious resources wasted on such units by identifying suitable units beforehand.
Export Options
About this article
Cite this article as:
Pafumi C., Gangarossa G., Lupo A., Randazzo C., Abate G., Rosa La I., Palumbo A. M., Iemmola A., Gulino F., Attard M. and Plesca C. A., Good Practice in Umbilical Cord Blood Collection in Order to Identify Suitable Units Before Cryopreservation, Letters in Drug Design & Discovery 2010; 7 (3) . https://dx.doi.org/10.2174/157018010790596623
DOI https://dx.doi.org/10.2174/157018010790596623 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exploring a Novel Target Treatment on Breast Cancer: Aloe-emodin Mediated Photodynamic Therapy Induced Cell Apoptosis and Inhibited Cell Metastasis
Anti-Cancer Agents in Medicinal Chemistry Pulmonary Embolism and Pregnancy
Current Women`s Health Reviews Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules
Anti-Cancer Agents in Medicinal Chemistry Biotransformation of Silybin and its Congeners
Current Drug Metabolism The Impact of Gynecological Cancer on Reproductive Issues and Pregnancy:Psychological Implications
Current Women`s Health Reviews Therapeutic Transfer of DNA Encoding Adenoviral E1A
Recent Patents on Anti-Cancer Drug Discovery Current Scenario of Acridine Hybrids with Anticancer Potential
Current Topics in Medicinal Chemistry Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors
Current Topics in Medicinal Chemistry Estrogens Acting as Cardiovascular Agents: Direct Vascular Actions
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Non-Steroidal Targets in the Diagnosis and Treatment of Endometriosis
Current Medicinal Chemistry A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin
Current Drug Targets Editorial [Hot Topic:Cervical Cancer - Current Challenges(Guest Editor: Adeola Olaitan)]
Current Women`s Health Reviews Circulating Nucleic Acids in Plasma and Serum: Roles in Diagnosis and Prognosis in Diabetes and Cancer
Infectious Disorders - Drug Targets Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?
Current Cancer Drug Targets Cervical Cancer During Pregnancy – An Approach to Diagnosis and Management
Current Women`s Health Reviews The Ovary Feels Fine when Paracrine and Autocrine Networks Cooperate with Gonadotropins in the Regulation of Folliculogenesis
Current Pharmaceutical Design Detection of Residual/Recurrent Cervical Disease after Successful LEEP Conization: the Possible Role of mRNA-HPV Test
Current Pharmaceutical Design Patents on Therapeutic and Cosmetic Applications of Bioactives of Crocus Sativus L. and their Production through Synthetic Biology Methods: A Review
Recent Patents on Biotechnology Peptides as Therapeutic Agents or Drug Leads for Autoimmune, Hormone Dependent and Cardiovascular Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Is Glyburide Safe in Pregnancy?
Current Pharmaceutical Biotechnology